Meet with… The Bill & Melinda Gates Foundation

Add this event to your calendar:
03/04/2018 12:30 03/04/2018 15:00 America/New_York Meet with… The Bill & Melinda Gates Foundation JLABS @ LabCentral , 700 Main St, North , Cambridge , MA 02139 Johnson & Johnson Innovation, JLABS false DD/MM/YYYY

Meet with… The Bill & Melinda Gates Foundation

JLABS @ LabCentral , 700 Main St, North , Cambridge , MA 02139

April 03, 2018 from 12:30 PM to 15:00 PM (EST)

$10 - $35

Program Overview:
The path out of poverty is paved with access to quality healthcare. Do you have solutions that will make a difference? The Bill & Melinda Gates Foundation is advancing science and technology to save lives in developing countries. The Foundation works with partners to deliver proven tools—including vaccines, drugs, and diagnostics—and discover groundbreaking new solutions that are affordable and reliable. Focus areas for investments center on infectious diseases including HIV, polio, TB, dengue and malaria, as well as diagnostics and health IT ideas that bring health interventions to people who need them most.

Charlotte Hubbert, Partner with Gates Foundation Venture Capital, will be in attendance to provide an overview presentation on the Foundation's key areas of interest and venture investment philosophy. Gates Foundation Venture Capital operates under the Program Related Investments group at the Bill & Melinda Gates foundation, which manages a $2B allocation for private sector investment.

Charlotte will be on hand to meet with a handful of applicants one-on-one after the presentation. To be considered for a one-on-one meeting, complete the information required at the link below.

10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on March 13, 2017. APPLY HERE.

Gates Foundation Representative:
Charlotte Hubbert, Ph.D. | Partner, Gates Foundation Venture Capital
Charlotte Hubbert is a Partner with Gates Foundation Venture Capital, investing in innovative technologies that support The Bill & Melinda Gates Foundation initiatives in Global Health and Agriculture. Charlotte currently serves on the board of directors of Synlogic, Sera Prognostics, Lodo Therapeutics, Omniome and Vir Biotechnology. Prior to joining the Gates Foundation, Charlotte was a Vice-President at H.I.G. BioVentures investing broadly in healthcare. Charlotte started her career in early stage biotech investing at Accelerator Corporation, where she was part of the founding team and management of five companies, Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori and Pharmselex.

Charlotte was recently honored as a Fierce Woman in Biopharma 2016 by FiercePharma, and as a leading Woman in Life Sciences 2016 by Life Science Washington. She serves on the BOD of Life Science Washington and the steering committee of the Fred Hutch Cancer Institute’s Evergreen Fund. Charlotte earned a B.S. in Microbiology from the University of Washington and a Ph.D. in Pharmacology and Cancer Biology from Duke University. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the UW. Charlotte is a member of the Kauffman Society of Fellows (Class 14).
Connect with Charlotte:   Connect on LinkedIn

$25 | General Public
$35 | Onsite

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period will close on March 13, 2017. Your application will be reviewed and you will be notified of acceptance by March 30, 2017. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Application Process: Open now       Application Deadline: March 13, 2017

JLABS @ LabCentral
700 Main St, North
Boston, MA 02139

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Welcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.

Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), New York City, and with Shanghai opening in 2019. For more information please visit or follow @JLABS.

Event contact

Related content